AHICE-Benefits in relation to the conservative,  school medicine tumourtherapy:

- High specificity and detection-ability against tumourcells, reached by complete “antigen specific” immune-stimulation and attack of patient´s own immune system (autologous production of complete cascade of immune-mediators / cytokines and related immune effectors, which are in vivo responsible for the specific activation of the immune system), and thereafter 

- start in vivo an “antigen-specific” immune-activation of the cellforms (dendritic cells, natural killer cells, macrophages and cytotoxic T-lymphocytes etc.), which are responsible for the elimination of the recognized antigens (tumourcells), via “apoptosis”, it means “programed cell-death”!

- In vivo antigen-specific attack against the solid tumours, their metastatic sites and their circulating tumourcells in the whole patient´s organism!

- There are non secondary effects observed during this active Immune-Tumourtherapy until now and it does not exist a possibility of viral infection, because of the autologous production of AHICE.

- In addition to the observed, remarkable good therapeutical effects, there is a significant increasing of quality of patients life to register.

- The in vivo Effectiveness is proved in March 2002 (metastatic Melanoma, male Patient), in 2003 and at last in Mai 2004(multiple metastatic ovarial carcinomas).

- The active immune-tumourtherapy AHICET is applicable on various carcinoma-kinds and -stages (exceptions at the moment: leucaemiae / lymphomas, small cell bronchial-Ca., thyroid gland-Ca., germcell-Ca.) and it can be repeated without any risks.

- The active immune-cancertherapy AHICE is simply to apply and to surveill the therapy result.

- This active immune-therapy AHICE can be applied also in combination with the conservative school medical tumourtherapy (e.g. radiation- and/or chemotherapy).

- Biotechnological production of the AHICE in compliance with the “german-drug-low (AMG)” and “good manufacturing practice(GMP)” of the European community low.

- Remarkable therapeutical successes also in auto-immune diseases, like rheumatism formula circle(rheumatoide arthritis), Hashimoto Thyreoiditis, were established.

Cooperative studies are desired for statistical verification about this with appropriate subject institutions.

Furthermore Informations:

K-BIO, Clinical Biochemical Institute for Cellbiotechnology and Immunology GmbH

Tel.:(0049)-(0)8142-52030, Fax:(0049)-(0)8142-580023

e-Mail: Info[at]K-BIO.de

Products    <= back...                      next... => Cytokine-ELISA´s